figshare
Browse
STROKEAHA.118.022128 Copy.pdf (64.4 kB)

Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non–Vitamin K Antagonist Oral Anticoagulants Preceding Stroke

Download (64.4 kB)
preprint
posted on 2019-05-07, 15:00 authored by Ying Xian
These preliminary observations suggest that tPA may be reasonably well tolerated without prohibitive risks of bleeding complications in selected patients on NOACs. Reversal of anticoagulant effects by idarucizumab for dabigatran-treated patients before tPA is an emerging strategy that was associated with more favorable outcomes

History

Grant ID

14SDG2046008

Usage metrics

    American Heart Association

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC